Table 1.
Baseline characteristics and hormones analysis of the population studied.
| Control group (n = 112) | PCOS group (n = 104) | p-value | |
|---|---|---|---|
| Age (years) | 30.48 ± 4.15 | 29.75 ± 3.60 | 0.169 |
| BMI (kg/m2) | 24.14 ± 3.64 | 25.35 ± 3.48 | 0.014* |
| FSH (IU/L) | 6.30 ± 1.50 | 5.60 ± 1.34 | 0.000** |
| LH (IU/L) | 5.08 ± 2.32 | 8.57 ± 4.75 | 0.000** |
| E2 (pg/ml) | 38.37 ± 24.82 | 38.87 ± 17.26 | 0.866 |
| P (ng/ml) | 0.30 ± 0.28 | 0.24 ± 0.19 | 0.090 |
| T (ng/dl) | 24.14 ± 11.43 | 37.37 ± 19.37 | 0.000** |
| TSH (µIU/ml) | 2.26 ± 0.96 | 2.27 ± 0.97 | 0.901 |
| PRL (ng/ml) | 16.02 ± 5.94 | 14.42 ± 6.28 | 0.056 |
| DHEA-s (g/dl) | 239.19 ± 85.65 | 287.57 ± 109.25 | 0.001** |
| AMH (ng/ml) | 4.18 ± 1.94 | 7.82 ± 3.63 | 0.000** |
BMI, body mass index; FSH, follicle-stimulating hormone; LH, luteinizing hormone; E2, estradiol; P, progestin; T, testosterone; TSH, thyroid-stimulating hormone; PRL, prolactin; DHEA-s, dehydroepiandrosterone; AMH, anti-Mullerian hormone.
*p < 0.05; **p < 0.01.